Fig. 2
Viabilities of (A, B) NIH/3 T3 and (C, D) MC3T3-E1 cells after treatment with NDs and Alen-NDs for (A, C) 24 h and (B, D) 48 h
Fig. 2 | Biomaterials Research
Viabilities of (A, B) NIH/3 T3 and (C, D) MC3T3-E1 cells after treatment with NDs and Alen-NDs for (A, C) 24 h and (B, D) 48 h